Application of platelet rich plasma in the treatment of pain syndrome in patients with plantar fasciitis

Authors

  • Olena Turchin SI «Institute of Traumatology and Orthopaedics of the NAMS of Ukraine», Kyiv, Ukraine
  • Lyudmila Osadchaya SI «Institute of Traumatology and Orthopaedics of the NAMS of Ukraine», Kyiv, Ukraine
  • Oleksandr Kostrub SI «Institute of Traumatology and Orthopaedics of the NAMS of Ukraine», Kyiv, Ukraine
  • Andrey Lyabakh SI «Institute of Traumatology and Orthopaedics of the NAMS of Ukraine», Kyiv, Ukraine

DOI:

https://doi.org/10.15674/0030-59872019185-90

Keywords:

platelet-rich plasma, foot, plantar fasciitis, plantar aponeurosis

Abstract

Objective: to analyze the results of the injection of plateletrich plasma (PRP) and prolonged-acting corticosteroids in patients with plantar fasciitis (PF).

Methods: 43 patients were examined (55 feet) with pain syndrome of PF. There were women 29, men — 14, average age (44 ± 1.41) years, average duration of the pain syndrome (3.5 ± 0.36) months. Together with the complex of conservative treatment for patients we prescribed locally injections: in group I (27 patients) — once 1 ml of betamethasone, in II group (16 patients) — PRP (2 ml three times with an interval of 7 days in the region of enthesis). The standard PRP method was used. The pain syndrome was evaluated with the help of VAS before, after 1, 3 and 6 months after treatment. Thickness of plantar aponeurosis (PA) was measured with sonography before and in 6 months after treatment.

Results: the average level of pain syndrome before the injections in the both groups were almost identical and amounted to (7.2 ± 0.17) and (7.3 ± 0.23) points, respectively. In a month after the injection in the Ist group, the pain syndrome significantly decreased to (3.5 ± 0.12) points, which confirms fast analgesic effect of manipulation. In the IInd group, the indicators of pain decreased to (4.6 ± 0.17) points. By 6 months the results were almost identical in both groups of patients. Thickness of PA before treatment was equal in the group І (6.62 ± 0.08) mm, in ІІ — (6.81 ± 0.1) mm, so there was no difference between them. After 6 months the thickness of PA was equally reduced in both groups: in the Ist — to (4.49 ± 0.07) mm, in the IInd — to (4.42 ± 0.09) mm, which is objective criterion for the positive therapeutic effect of both methods of treatment.

Conclusions: injections of PRP and prolonged-action corticosteroids provide the same positive results in the treatment of pain syndrome in patients with PF. Effect of corticosteroids is fast, but their use is limited due to a number of complications. The introduction of PRP helps to reduce pain syndrome and to normalize thickness of PA.

Author Biographies

Olena Turchin, SI «Institute of Traumatology and Orthopaedics of the NAMS of Ukraine», Kyiv

PhD in Traumatology and Orthopаedics

Oleksandr Kostrub, SI «Institute of Traumatology and Orthopaedics of the NAMS of Ukraine», Kyiv

MD, Prof. in Traumatology and Orthopаedics

Andrey Lyabakh, SI «Institute of Traumatology and Orthopaedics of the NAMS of Ukraine», Kyiv

MD, Prof. in Traumatology and Orthopаedics

References

  1. Franceschi, F., Papalia, R., Paciotti, M., Franceschetti, E., Di Martino, A., Maffulli, N., & Denaro, V. (2014). Obesity as a Risk Factor for Tendinopathy: A Systematic Review. International Journal of Endocrinology, 2014, 670262. doi:10.1155/2014/670262
  2. Thing, J., Maruthappu, M., & Rogers, J. (2012). Diagnosis and management of plantar fasciitis in primary care. British Journal of General Practice, 62 (601), 443–444. doi:10.3399/bjgp12x653769
  3. Waclawski, E. R., Beach, J., Milne, A., Yacyshyn, E., & Dryden, D. M. (2015). Systematic review: plantar fasciitis and prolonged weight bearing. Occupational Medicine, 65 (2), 97–106. doi:10.1093/occmed/kqu177
  4. Li, S., Wang, K., Sun, H., Luo, X., Wang, P., Fang, S., & Sun, X. (2018). Clinical effects of extracorporeal shock-wave therapy and ultrasound-guided local corticosteroid injections for plantar fasciitis in adults. Medicine, 97 (50), e13687. doi:10.1097/md.0000000000013687
  5. Li, X., Zhang, L., Gu, S., Sun, J., Qin, Z., Yue, J., & Gao, R. (2018). Comparative effectiveness of extracorporeal shock wave, ultrasound, low-level laser therapy, noninvasive interactive neurostimulation, and pulsed radiofrequency treatment for treating plantar fasciitis. Medicine, 97 (43), e12819. doi:10.1097/md.0000000000012819
  6. Kim, C., Cashdollar, M. R., Mendicino, R. W., Catanzariti, A. R., & Fuge, L. (2010). Incidence of Plantar Fascia Ruptures Following Corticosteroid Injection. Foot & Ankle Specialist, 3 (6), 335–337. doi:10.1177/1938640010378530
  7. Ragab, E. M., & Othman, A. M. (2012). Platelets rich plasma for treatment of chronic plantar fasciitis. Archives of Orthopaedic and Trauma Surgery, 132 (8), 1065–1070. doi:10.1007/s00402-012-1505-8
  8. Martinelli, N., Marinozzi, A., Carnì, S., Trovato, U., Bianchi, A., & Denaro, V. (2012). Platelet-rich plasma injections for chronic plantar fasciitis. International Orthopaedics, 37 (5), 839–842. doi:10.1007/s00264-012-1741-0
  9. Malahias, M., Mavrogenis, A. F., Nikolaou, V. S., Megaloikonomos, P. D., Kazas, S. T., Chronopoulos, E., & Babis, G. C. (2019). Similar effect of ultrasound-guided platelet-rich plasma versus platelet-poor plasma injections for chronic plantar fasciitis. The Foot, 38, 30–33. doi:10.1016/j.foot.2018.11.003
  10. Shetty, S. H., Dhond, A., Arora, M., & Deore, S. (2019). Platelet-Rich Plasma Has Better Long-Term Results Than Corticosteroids or Placebo for Chronic Plantar Fasciitis: Randomized Control Trial. The Journal of Foot and Ankle Surgery, 58 (1), 42–46. doi:10.1053/j.jfas.2018.07.006
  11. Kampa, R. J., & Connell, D. A. (2010). Treatment of tendinopathy: is there a role for autologous whole blood and platelet rich plasma injection? International Journal of Clinical Practice, 64 (13), 1813–1823. doi:10.1111/j.1742-1241.2010.02432.x
  12. Amini, F., Chiew, S., & Ramasamy, T. (2016). Effectiveness and relevant factors of platelet-rich plasma treatment in managing plantar fasciitis:A systematic review. Journal of Research in Medical Sciences, 21 (1), 38. doi:10.4103/1735-1995.183988
  13. Jiménez-Pérez, A. E., Gonzalez-Arabio, D., Diaz, A. S., Maderuelo, J. A., & Ramos-Pascua, L. R. (2018). Clinical and imaging effects of corticosteroids and platelet-rich plasma for the treatment of chronic plantar fasciitis: A comparative non randomized prospective study. Foot and Ankle Surgery, pii: S1268-7731(18)30023-7. doi:10.1016/j.fas.2018.01.005
  14. WHO :: Global Database on Body Mass Index. (n.d.). Retrieved from http://apps.who.int/bmi/index.jsp
  15. Sherpy, N. A., Hammad, M. A., Hagrass, H. A., Samir, H., Abu-ElMaaty, S. E., & Mortada, M. A. (2016). Local injection of autologous platelet rich plasma compared to corticosteroid treatment of chronic plantar fasciitis patients: A clinical and ultrasonographic follow-up study. The Egyptian Rheumatologist, 38 (3), 247–252. doi:10.1016/j.ejr.2015.09.008
  16. Shetty, V. D., Dhillon, M., Hegde, C., Jagtap, P., & Shetty, S. (2014). A study to compare the efficacy of corticosteroid therapy with platelet-rich plasma therapy in recalcitrant plantar fasciitis: A preliminary report. Foot and Ankle Surgery, 20 (1), 10–13. doi:10.1016/j.fas.2013.08.002
  17. Say, F., Gürler, D., Inkaya, E., & Bülbül, M. (2014). Comparison of platelet-rich plasma and steroid injection in the treatment of plantar fasciitis. Acta Orthopaedica et Traumatologica Turcica, 48 (6), 667–672. doi:10.3944/aott.2014.13.0142
  18. Jain, K., Murphy, P. N., & Clough, T. M. (2015). Platelet rich plasma versus corticosteroid injection for plantar fasciitis: A comparative study. The Foot, 25 (4), 235–237. doi:10.1016/j.foot.2015.08.006
  19. Ragab, E. M., & Othman, A. M. (2012). Platelets rich plasma for treatment of chronic plantar fasciitis. Archives of Orthopaedic and Trauma Surgery, 132 (8), 1065–1070. doi:10.1007/s00402-012-1505-8
  20. Chew, K. T., Leong, D., Lin, C. Y., Lim, K. K., & Tan, B. (2013). Comparison of Autologous Conditioned Plasma Injection, Extracorporeal Shockwave Therapy, and Conventional Treatment for Plantar Fasciitis: A Randomized Trial. PM&R, 5 (12), 1035–1043. doi:10.1016/j.pmrj.2013.08.590
  21. Kalaci, A., Çakici, H., Hapa, O., Yanat, A. N., Dogramaci, Y., & Sevinç, T. T. (2009). Treatment of Plantar Fasciitis Using Four Different Local Injection Modalities. Journal of the American Podiatric Medical Association, 99 (2), 108–113. doi:10.7547/0980108
  22. Gosens, T., Den Oudsten, B. L., Fievez, E., Van ‘t Spijker, P., & Fievez, A. (2012). Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. International Orthopaedics, 36 (9), 1941–1946. doi:10.1007/s00264-012-1540-7

Downloads

How to Cite

Turchin, O., Osadchaya, L., Kostrub, O., & Lyabakh, A. (2023). Application of platelet rich plasma in the treatment of pain syndrome in patients with plantar fasciitis. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (1), 85–90. https://doi.org/10.15674/0030-59872019185-90

Issue

No. 1 (2019)

Section

ORIGINAL ARTICLES

License

Copyright (c) 2019 Olena Turchin, Lyudmila Osadchaya, Oleksandr Kostrub, Andrey Lyabakh

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).